Skip to content

Metabolic Syndrome Prevalence Study

Turkey Metabolic Syndrome Prevalence Study - METSAR II

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02379702
Enrollment
1659
Registered
2015-03-05
Start date
2014-06-30
Completion date
2014-11-30
Last updated
2015-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Brief summary

Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

Detailed description

In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.

Interventions

OTHERMetabolic Syndrome

This study will provide important information on the social and economic dimensions of metabolic syndrome

Sponsors

Abdi Ibrahim Ilac San. ve Tic A.S.
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Volunteers who participated in the METSAR-I study in 2003 * Patients who accepted to participate will be included the second follow up phase.

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frame
comorbidities and changes in general health10 year

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026